Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Philipp Mandel

Showing results (61-70 of 220) with videos related to

Pageof 22
Sort By:
Urologic Oncology|November 26, 2015
Five-year biochemical recurrence-free and overall survival following high-dose-rate brachytherapy with additional external beam or radical prostatectomy in patients with clinically localized prostate cancerKatharina Boehm, Jonas Schiffmann, Zhe Tian, et al.
Urologic Oncology|October 9, 2025
Use of staging in intermediate-risk prostate cancer: A real-world data analysisBen Frederik Hartwieg, Tobias Maurer, Christopher Kniep, et al.
Frontiers in Surgery|January 13, 2018
AB0/Rhesus Blood Group Does Not Influence Clinicopathological Tumor Characteristics or Oncological Outcome in Patients Undergoing Radical ProstatectomySu Jung Oh, Philipp Mandel, Felix K H Chun, et al.
European Urology Focus|June 17, 2018
Interrupted versus Continuous Suturing for Vesicourethral Anastomosis During Radical Prostatectomy: A Systematic Review and Meta-analysisKarl F Kowalewski, Christian Tapking, Svetlana Hetjens, et al.
Frontiers in Oncology|February 19, 2025
The association between the interval from biopsy to radical prostatectomy and biochemical recurrence in patients with intermediate- and high-risk prostate cancerCarolin Siech, Mike Wenzel, Georgina Knoblich, et al.
Urologia Internationalis|September 13, 2021
Catheterization Does Not Improve Course of Disease in Female Patients with Acute Cystitis or Pyelonephritis: Retrospective Analysis of >300 In-Hospital Treated PatientsMike Wenzel, Benedikt Hoeh, Konstatin Goeldner, et al.
BJU International|October 16, 2016
Adjuvant radiation therapy is associated with better oncological outcome compared with salvage radiation therapy in patients with pN1 prostate cancer treated with radical prostatectomyDerya Tilki, Felix Preisser, Pierre Tennstedt, et al.
World Journal of Urology|December 28, 2024
Androgen receptor pathway inhibitors vs. docetaxel chemotherapy for metastatic hormone-sensitive and first-line castration resistant prostate cancerMike Wenzel, Benedikt Hoeh, Clara Humke, et al.
Cancers|July 27, 2022
Impact of Statin Use on Localized Prostate Cancer Outcomes after Radiation Therapy: Long-Term Follow-UpKevin Kaulanjan, Danny Lavigne, Fred Saad, et al.
World Journal of Urology|June 4, 2020
Holmium laser enucleation of the prostate: efficacy, safety and preoperative management in patients presenting with anticoagulation therapyMarina Deuker, Jessica Rührup, Pierre I Karakiewicz, et al.
Pageof 22

Showing results (61-70 of 220) with videos related to

Sort By:
Pageof 22
Urologic Oncology|November 26, 2015
Five-year biochemical recurrence-free and overall survival following high-dose-rate brachytherapy with additional external beam or radical prostatectomy in patients with clinically localized prostate cancerKatharina Boehm, Jonas Schiffmann, Zhe Tian, et al.
Urologic Oncology|October 9, 2025
Use of staging in intermediate-risk prostate cancer: A real-world data analysisBen Frederik Hartwieg, Tobias Maurer, Christopher Kniep, et al.
Frontiers in Surgery|January 13, 2018
AB0/Rhesus Blood Group Does Not Influence Clinicopathological Tumor Characteristics or Oncological Outcome in Patients Undergoing Radical ProstatectomySu Jung Oh, Philipp Mandel, Felix K H Chun, et al.
European Urology Focus|June 17, 2018
Interrupted versus Continuous Suturing for Vesicourethral Anastomosis During Radical Prostatectomy: A Systematic Review and Meta-analysisKarl F Kowalewski, Christian Tapking, Svetlana Hetjens, et al.
Frontiers in Oncology|February 19, 2025
The association between the interval from biopsy to radical prostatectomy and biochemical recurrence in patients with intermediate- and high-risk prostate cancerCarolin Siech, Mike Wenzel, Georgina Knoblich, et al.
Urologia Internationalis|September 13, 2021
Catheterization Does Not Improve Course of Disease in Female Patients with Acute Cystitis or Pyelonephritis: Retrospective Analysis of >300 In-Hospital Treated PatientsMike Wenzel, Benedikt Hoeh, Konstatin Goeldner, et al.
BJU International|October 16, 2016
Adjuvant radiation therapy is associated with better oncological outcome compared with salvage radiation therapy in patients with pN1 prostate cancer treated with radical prostatectomyDerya Tilki, Felix Preisser, Pierre Tennstedt, et al.
World Journal of Urology|December 28, 2024
Androgen receptor pathway inhibitors vs. docetaxel chemotherapy for metastatic hormone-sensitive and first-line castration resistant prostate cancerMike Wenzel, Benedikt Hoeh, Clara Humke, et al.
Cancers|July 27, 2022
Impact of Statin Use on Localized Prostate Cancer Outcomes after Radiation Therapy: Long-Term Follow-UpKevin Kaulanjan, Danny Lavigne, Fred Saad, et al.
World Journal of Urology|June 4, 2020
Holmium laser enucleation of the prostate: efficacy, safety and preoperative management in patients presenting with anticoagulation therapyMarina Deuker, Jessica Rührup, Pierre I Karakiewicz, et al.
Pageof 22